chrX-51744836-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_018094.5(GSPT2):āc.1210T>Gā(p.Phe404Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000497 in 1,207,003 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018094.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GSPT2 | NM_018094.5 | c.1210T>G | p.Phe404Val | missense_variant | 1/1 | ENST00000340438.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GSPT2 | ENST00000340438.6 | c.1210T>G | p.Phe404Val | missense_variant | 1/1 | NM_018094.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000895 AC: 1AN: 111781Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33935
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183393Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67867
GnomAD4 exome AF: 0.00000457 AC: 5AN: 1095222Hom.: 0 Cov.: 30 AF XY: 0.00000832 AC XY: 3AN XY: 360638
GnomAD4 genome AF: 0.00000895 AC: 1AN: 111781Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33935
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.1210T>G (p.F404V) alteration is located in exon 1 (coding exon 1) of the GSPT2 gene. This alteration results from a T to G substitution at nucleotide position 1210, causing the phenylalanine (F) at amino acid position 404 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at